Skip to content
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Gynecology

Symptoms & Biology of Adenomyosis

At a Glance

Adenomyosis is a structural uterine condition driven by an estrogen-inflammation cycle. It causes the uterine lining to grow into the muscle wall, leading to severe cramps, heavy menstrual bleeding, and an enlarged uterus. It is frequently misdiagnosed as fibroids or endometriosis.

Adenomyosis is more than just “painful periods.” It is a structural medical condition that fundamentally changes the biology and shape of your uterus. For many patients, the diagnosis comes after years of being told their symptoms were normal, when in reality, their bodies were caught in a complex biological loop of inflammation and hormonal imbalance [1][2].

The Hallmark Symptoms

The symptoms of adenomyosis are often progressive, meaning they can start as manageable discomfort and gradually worsen over several years [3]. The two most common experiences are:

  • Heavy Menstrual Bleeding (HMB): This is not just a heavy flow; it often involves soaking through products quickly or passing large blood clots. In the medical world, adenomyosis is officially classified as a structural cause of bleeding under the PALM-COEIN system (a medical checklist doctors use to categorize causes of abnormal bleeding, where adenomyosis is the ‘A’ in PALM) [4][5].
  • Severe Dysmenorrhea: This refers to intense, often “labor-like” cramping. Because the endometrial tissue is trapped inside the uterine muscle, it bleeds and swells during your period, creating intense internal pressure [6][7].

Other symptoms can include dyspareunia (pain during or after intercourse), a persistent feeling of pelvic heaviness, and an enlarged or “bulky” uterus that may cause your lower abdomen to feel tender or look slightly bloated [3][8].

The Biology: A Vicious Cycle

At the heart of adenomyosis is a self-sustaining cycle between your hormones and your immune system [9].

  1. Estrogen Dominance: Adenomyosis tissue is highly sensitive to estrogen. In fact, the diseased areas of the uterine wall can actually produce their own extra estrogen locally [10]. This creates an environment of hyper-estrogenism, which causes the rogue tissue to grow and invade deeper into the muscle [10].
  2. The Inflammatory Loop: This extra estrogen triggers the release of inflammatory chemicals (like cytokines and prostaglandins) [9][11]. These chemicals cause more pain and, importantly, signal the body to produce even more estrogen.
  3. Structural Changes: Over time, this chronic inflammation causes the uterine muscle to become scarred and thickened (fibrosis) [12]. This stiffening of the muscle prevents the uterus from contracting efficiently to stop menstrual bleeding, which is why the bleeding becomes heavier as the disease progresses [13].

Why Is It Often Misdiagnosed?

Because the symptoms of adenomyosis are similar to other pelvic conditions, it is frequently mistaken for something else. The most common “mimics” include:

  • Uterine Fibroids: These are firm, non-cancerous growths. While they also cause heavy bleeding, they are distinct lumps, whereas adenomyosis is an invasion of the muscle itself [14].
  • Endometriosis: This involves similar tissue growing outside the uterus. It is very common for a patient to have both, which can make it hard to tell which condition is causing which specific pain [15][16].

Understanding that your symptoms have a clear biological cause—a structural change in the uterine wall driven by a cycle of estrogen and inflammation—is key to moving past “dismissed” symptoms and toward targeted treatment [17][18].

Return to Home Page

Common questions in this guide

Why does adenomyosis cause such heavy menstrual bleeding?
Adenomyosis causes the uterine muscle to thicken and scar over time. This stiffening prevents the uterus from contracting properly to stop menstrual bleeding, resulting in a heavier flow and large blood clots.
Is adenomyosis the same as endometriosis?
No, though they share similarities and often occur together. Adenomyosis involves endometrial-like tissue growing into the muscle wall of the uterus, while endometriosis involves similar tissue growing outside the uterus.
What does it mean to have an enlarged or bulky uterus?
As adenomyosis tissue grows and bleeds within the uterine wall, the muscle swells and thickens due to chronic inflammation. This structural change causes the entire uterus to become enlarged, which doctors often describe as a bulky uterus.
How do hormones affect adenomyosis symptoms?
Adenomyosis tissue is highly sensitive to estrogen and can even produce its own extra estrogen locally. This creates a cycle where high estrogen drives tissue growth and inflammation, which in turn causes more pain and heavier bleeding.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my ultrasound show any other structural issues, like fibroids, that might be contributing to my heavy bleeding?
  2. 2.Where does my adenomyosis fit into the PALM-COEIN system for abnormal uterine bleeding?
  3. 3.Is my uterine enlargement 'diffuse' or 'focal,' and how does that affect the severity of my symptoms?
  4. 4.Based on the 'estrogen dominance' involved in this condition, would hormonal treatments like dienogest or a levonorgestrel IUD be effective for me?
  5. 5.Since adenomyosis and endometriosis often occur together, were there any signs of endometriosis found during my scans?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    Method used to identify adenomyosis and potentially undiagnosed adenomyosis in a large, U.S. electronic health record database.

    Loughlin AM, Chiuve SE, Reznor G, et al.

    Pharmacoepidemiology and drug safety 2021; (30(12)):1675-1686 doi:10.1002/pds.5333.

    PMID: 34292640
  2. 2

    Women's experiences of living with adenomyosis and perceptions of the diagnostic journey: a scoping review.

    Taylor MA, Croudace TJ, Muir FE, McBride M

    BMJ open 2025; (15(1)):e087122 doi:10.1136/bmjopen-2024-087122.

    PMID: 39832979
  3. 3

    Adenomyosis diagnosis among adolescents and young women with dysmenorrhoea and heavy menstrual bleeding.

    Vannuccini S, Meleca C, Toscano F, et al.

    Reproductive biomedicine online 2024; (48(5)):103768 doi:10.1016/j.rbmo.2023.103768.

    PMID: 38432071
  4. 4

    Prevalence of abnormal uterine bleeding according to new International Federation of Gynecology and Obstetrics classification in Chinese women of reproductive age: A cross-sectional study.

    Sun Y, Wang Y, Mao L, et al.

    Medicine 2018; (97(31)):e11457 doi:10.1097/MD.0000000000011457.

    PMID: 30075511
  5. 5

    Comparison of classic terminology with the FIGO PALM-COEIN system for classification of the underlying causes of abnormal uterine bleeding.

    Töz E, Sancı M, Özcan A, et al.

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2016; (133(3)):325-8.

    PMID: 26952349
  6. 6

    Adenomyosis: the missed disease.

    Santulli P, Vannuccini S, Bourdon M, et al.

    Reproductive biomedicine online 2025; (50(4)):104837 doi:10.1016/j.rbmo.2025.104837.

    PMID: 40287215
  7. 7

    Introduction: Uterine adenomyosis, another enigmatic disease of our time.

    Donnez J, Donnez O, Dolmans MM

    Fertility and sterility 2018; (109(3)):369-370 doi:10.1016/j.fertnstert.2018.01.035.

    PMID: 29526476
  8. 8

    Expression of Inflammatory and Neurogenic Mediators in Adenomyosis.

    Carrarelli P, Yen CF, Funghi L, et al.

    Reproductive sciences (Thousand Oaks, Calif.) 2017; (24(3)):369-375 doi:10.1177/1933719116657192.

    PMID: 27440813
  9. 9

    The interaction between inflammation and estrogen in adenomyosis : from molecular mechanisms to therapeutic strategies.

    Li F, Wang HJ, Zhang Y, et al.

    Seminars in immunopathology 2026; (48(1)).

    PMID: 42258013
  10. 10

    Hormone receptor profile of ectopic and eutopic endometrium in adenomyosis: a systematic review.

    Maclean A, Tipple L, Newton E, Hapangama DK

    Human reproduction open 2025; (2025(1)):hoaf002 doi:10.1093/hropen/hoaf002.

    PMID: 39935764
  11. 11

    Increased chemokine ligand 26 expression and its involvement in epithelial-mesenchymal transition in the endometrium with adenomyosis.

    Ikebuchi A, Osaki M, Wada I, et al.

    Journal of gynecology obstetrics and human reproduction 2023; (52(9)):102645 doi:10.1016/j.jogoh.2023.102645.

    PMID: 37597576
  12. 12

    Endometrial Inflammation and Impaired Spontaneous Decidualization: Insights into the Pathogenesis of Adenomyosis.

    Kobayashi H

    International journal of environmental research and public health 2023; (20(4)) doi:10.3390/ijerph20043762.

    PMID: 36834456
  13. 13

    Pathogenesis of adenomyosis: an update on molecular mechanisms.

    Vannuccini S, Tosti C, Carmona F, et al.

    Reproductive biomedicine online 2017; (35(5)):592-601 doi:10.1016/j.rbmo.2017.06.016.

    PMID: 28693952
  14. 14

    Factors associated with hysterectomy after failure of levonorgestrel-releasing intrauterine system treatment in women with abnormal uterine bleeding.

    Erkal N, Kaba M, Erdoğan K, et al.

    BMC women's health 2026; (26(1)).

    PMID: 41840553
  15. 15

    Systemic comorbidities in patients with adenomyosis.

    Gallone A, Vannuccini S, Manzi V, et al.

    Reproductive biomedicine online 2025; (51(6)):105102 doi:10.1016/j.rbmo.2025.105102.

    PMID: 41176881
  16. 16

    Adenomyosis Localized in Both the Anterior and Posterior Myometrium Is Associated with Deep Rectal Endometriosis: A Retrospective Study.

    Schawlochow K, Samartzis N, Burla L, et al.

    Biomedicines 2024; (12(11)) doi:10.3390/biomedicines12112527.

    PMID: 39595092
  17. 17

    Diagnostic accuracy of clinically reported adenomyosis on pelvic ultrasound and MRI compared to surgical pathology.

    Zanolli NC, Cline BC, Befera NT, Martin JG

    Clinical imaging 2022; (82()):117-120 doi:10.1016/j.clinimag.2021.11.012.

    PMID: 34808582
  18. 18

    Expert Consensus on the Management of Adenomyosis: A Modified Delphi Method Approach by the Taiwan Endometriosis Society.

    Lin CW, Ou HT, Wu MH, et al.

    Gynecology and minimally invasive therapy 2025; (14(1)):24-32 doi:10.4103/gmit.GMIT-D-24-00055.

    PMID: 40143988

This page provides educational information about the symptoms and biology of adenomyosis. Always consult your gynecologist or healthcare provider for an accurate diagnosis and treatment plan tailored to your specific symptoms.

Get notified when new evidence is published on adenomyosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.